Reports
Reports
Sale
Increasing Prevalence of Cardiopulmonary Diseases to Affect the Market Landscape Significantly
With rising incidence of cardiopulmonary conditions, the market has been witnessing an influx of new and innovative products to provide enhanced patient outcomes. According to World Health Organization (WHO), approximately 17.9 million people died from cardiovascular diseases in 2019, which represents 32% of all global deaths. With the rise in aging population, WHO estimates that between 2015 and 2050, the proportion of the world's population aged above 60 years will nearly double from 12% to 22%. Since geriatric population is more susceptible to develop chronic conditions, the market value for cardiopulmonary bypass equipment is likely to grow.
Growth in Strategic Partnerships and Mergers to Meet Rising Cardiopulmonary Bypass Equipment Market Demand
In April 2024, NuvoAir Medical partnered with Privia Medical Group to provide virtual-first care model and transform cardiopulmonary care. The partnership focused on leveraging NuvoAir's advanced digital health technologies to enhance the management of cardiopulmonary diseases, making healthcare more accessible and efficient. By integrating these technologies, the partnership aims to offer continuous, high-quality care outside conventional healthcare settings. The patients can benefit from real-time monitoring of their respiratory health, personalized treatment adjustments, and direct communication with healthcare providers, from wherever they are.
In July 2023, Inspira ™ Technologies entered into a collaboration agreement with Perfusion Solution, Inc. This collaboration involved combining Inspira™ Technologies' innovative oxygenation technology, INSPIRA™ ART100 product with Perfusion Solution's expertise in perfusion systems. Such collaborations are aimed at developing and refining solutions in order to improve patient outcomes during critical care and surgical procedures, propelling the market value in the forecast period.
Cardiopulmonary Bypass Equipment Market Size
Cardiopulmonary Bypass Equipment Market Growth
Cardiopulmonary Bypass Equipment Market Trends
Cardiopulmonary Bypass Equipment Market Share
Cardiopulmonary Bypass Equipment Market Regional Analysis
Cardiopulmonary Bypass Equipment Companies
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Cardiopulmonary Bypass Equipment Market Overview
3.1 Global Cardiopulmonary Bypass Equipment Market Historical Value (2017-2023)
3.2 Global Cardiopulmonary Bypass Equipment Market Forecast Value (2024-2032)
4 Global Cardiopulmonary Bypass Equipment Market Landscape*
4.1 Global Cardiopulmonary Bypass Equipment: Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Cardiopulmonary Bypass Equipment: Product Landscape
4.2.1 Analysis by Product
4.2.2 Analysis by Application
5 Global Cardiopulmonary Bypass Equipment Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.2.1 Strengths
5.2.2 Weaknesses
5.2.3 Opportunities
5.2.4 Threats
5.3 Porter’s Five Forces Model
5.3.1 Bargaining Power of Suppliers
5.3.2 Bargaining Power of Buyers
5.3.3 Threat of New Entrants
5.3.4 Threat of Substitutes
5.3.5 Degree of Rivalry
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Cardiopulmonary Bypass Equipment Market Segmentation (2017-2032)
6.1 Global Cardiopulmonary Bypass Equipment Market (2017-2032) by Product
6.1.1 Market Overview
6.1.2 Heart–Lung Machines
6.1.3 Oxygenators
6.1.4 Autotransfusion Systems
6.1.5 Others
6.2 Global Cardiopulmonary Bypass Equipment Market (2017-2032) by Application
6.2.1 Market Overview
6.2.2 Cardiovascular
6.2.3 Respiratory
6.2.4 Hemodialysis
6.2.5 Others
6.3 Global Cardiopulmonary Bypass Equipment Market (2017-2032) by Type
6.3.1 Market Overview
6.3.2 Single Roller Pump
6.3.3 Double Roller Pump
6.4 Global Cardiopulmonary Bypass Equipment Market (2017-2032) by End User
6.4.1 Market Overview
6.4.2 Hospitals
6.4.3 Specialty Clinics
6.4.4 Dialysis Centers
6.4.5 Ambulatory Surgery Centers
6.5 Global Cardiopulmonary Bypass Equipment Market (2017-2032) by Region
6.5.1 Market Overview
6.5.2 North America
6.5.3 Europe
6.5.4 Asia Pacific
6.5.5 Latin America
6.5.6 Middle East and Africa
7 North America Cardiopulmonary Bypass Equipment Market (2017-2032)
7.1 North America Cardiopulmonary Bypass Equipment Market (2017-2032) by Product
7.1.1 Market Overview
7.1.2 Heart–Lung Machines
7.1.3 Oxygenators
7.1.4 Autotransfusion Systems
7.1.5 Others
7.2 North America Cardiopulmonary Bypass Equipment Market (2017-2032) by Application
7.2.1 Market Overview
7.2.2 Cardiovascular
7.2.3 Respiratory
7.2.4 Hemodialysis
7.2.5 Others
7.3 North America Cardiopulmonary Bypass Equipment Market (2017-2032) by Country
7.3.1 United States of America
7.3.2 Canada
8 Europe Cardiopulmonary Bypass Equipment Market (2017-2032)
8.1 Europe Cardiopulmonary Bypass Equipment Market (2017-2032) by Product
8.1.1 Market Overview
8.1.2 Heart–Lung Machines
8.1.3 Oxygenators
8.1.4 Autotransfusion Systems
8.1.5 Others
8.2 Europe Cardiopulmonary Bypass Equipment Market (2017-2032) by Application
8.2.1 Market Overview
8.2.2 Cardiovascular
8.2.3 Respiratory
8.2.4 Hemodialysis
8.2.5 Others
8.3 Europe Cardiopulmonary Bypass Equipment Market (2017-2032) by Country
8.3.1 United Kingdom
8.3.2 Germany
8.3.3 France
8.3.4 Italy
8.3.5 Others
9 Asia Pacific Cardiopulmonary Bypass Equipment Market (2017-2032)
9.1 Asia Pacific Cardiopulmonary Bypass Equipment Market (2017-2032) by Product
9.1.1 Market Overview
9.1.2 Heart–Lung Machines
9.1.3 Oxygenators
9.1.4 Autotransfusion Systems
9.1.5 Others
9.2 Asia Pacific Cardiopulmonary Bypass Equipment Market (2017-2032) by Application
9.2.1 Market Overview
9.2.2 Cardiovascular
9.2.3 Respiratory
9.2.4 Hemodialysis
9.2.5 Others
9.3 Asia Pacific Cardiopulmonary Bypass Equipment Market (2017-2032) by Country
9.3.1 China
9.3.2 Japan
9.3.3 India
9.3.4 ASEAN
9.3.5 Australia
9.3.6 Others
10 Latin America Cardiopulmonary Bypass Equipment Market (2017-2032)
10.1 Latin America Cardiopulmonary Bypass Equipment Market (2017-2032) by Product
10.1.1 Market Overview
10.1.2 Heart–Lung Machines
10.1.3 Oxygenators
10.1.4 Autotransfusion Systems
10.1.5 Others
10.2 Latin America Cardiopulmonary Bypass Equipment Market (2017-2032) by Application
10.2.1 Market Overview
10.2.2 Cardiovascular
10.2.3 Respiratory
10.2.4 Hemodialysis
10.2.5 Others
10.3 Latin America Cardiopulmonary Bypass Equipment Market (2017-2032) by Country
10.3.1 Brazil
10.3.2 Argentina
10.3.3 Mexico
10.3.4 Others
11 Middle East and Africa Cardiopulmonary Bypass Equipment Market (2017-2032)
11.1 Middle East and Africa Cardiopulmonary Bypass Equipment Market (2017-2032) by Product
11.1.1 Market Overview
11.1.2 Heart–Lung Machines
11.1.3 Oxygenators
11.1.4 Autotransfusion Systems
11.1.5 Others
11.2 Middle East and Africa Cardiopulmonary Bypass Equipment Market (2017-2032) by Application
11.2.1 Market Overview
11.2.2 Cardiovascular
11.2.3 Respiratory
11.2.4 Hemodialysis
11.2.5 Others
11.3 Middle East and Africa Cardiopulmonary Bypass Equipment Market (2017-2032) by Country
11.3.1 Saudi Arabia
11.3.2 United Arab Emirates
11.3.3 Nigeria
11.3.4 South Africa
11.3.5 Others
12 Regulatory Framework
12.1 Regulatory Overview
12.1.1 US FDA
12.1.2 EU EMA
12.1.3 INDIA CDSCO
12.1.4 JAPAN PMDA
12.1.5 Others
13 Patent Analysis
13.1 Analysis by Type of Patent
13.2 Analysis by Publication Year
13.3 Analysis by Issuing Authority
13.4 Analysis by Patent Age
13.5 Analysis by CPC Analysis
13.6 Analysis by Patent Valuation
13.7 Analysis by Key Players
14 Grants Analysis
14.1 Analysis by Year
14.2 Analysis by Amount Awarded
14.3 Analysis by Issuing Authority
14.4 Analysis by Grant Application
14.5 Analysis by Funding Institute
14.6 Analysis by Departments
14.7 Analysis by Recipient Organization
15 Funding and Investment Analysis
15.1 Analysis by Funding Instances
15.2 Analysis by Type of Funding
15.3 Analysis by Funding Amount
15.4 Analysis by Leading Players
15.5 Analysis by Leading Investors
15.6 Analysis by Geography
16 Partnership and Collaborations Analysis
16.1 Analysis by Partnership Instances
16.2 Analysis by Type of Partnership
16.3 Analysis by Leading Players
16.4 Analysis by Geography
17 Supplier Landscape
17.1 Market Share by Top 5 Companies
17.2 Medtronic PLC
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 LivaNova PLC
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 MAQUET Holding B.V. & Co. KG.
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Terumo Corporation
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Braile Biomedica Ltd
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Tianjin Medical
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Senko Medical Instrument Manufacturing Co. Ltd.
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Abbott
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 Becton, Dickinson and Company
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 Beijing ZKSK Technology Co., Ltd.
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 Nipro Corporation
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
17.13 MicroPort Scientific Corporation
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisitions
17.13.5 Certifications
17.14 Precision Medical, Inc.
17.14.1 Financial Analysis
17.14.2 Product Portfolio
17.14.3 Demographic Reach and Achievements
17.14.4 Mergers and Acquisitions
17.14.5 Certifications
17.15 Zimmer Biomet Holdings, Inc.
17.15.1 Financial Analysis
17.15.2 Product Portfolio
17.15.3 Demographic Reach and Achievements
17.15.4 Mergers and Acquisitions
17.15.5 Certifications
17.16 Technowood Corporation
17.16.1 Financial Analysis
17.16.2 Product Portfolio
17.16.3 Demographic Reach and Achievements
17.16.4 Mergers and Acquisitions
17.16.5 Certifications
18 Global Cardiopulmonary Bypass Equipment Market – Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
* The coverage of the Market Landscape section depends on the data availability and may cover a minimum of 80% of the total market. The EMR team strives to make this section as comprehensive as possible.
Datasheet
Single User License
Five User License
Corporate License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.